Abstract:Background and Purpose: Probenecid (PROB) has been used for decades to treat gouty arthritis with few side effects and recent studies revealed that it is also a specific inhibitor of pannexin-1 channel. Panx1 channel was activated by ischemic injury and inhibition of the panx1 channel maybe efficacious in stroke treatment. However, the role of PROB in cerebral ischemia /reperfusion (I/R) injury remains unclear. The aim of this study was to investigate the role of PROB in the transient global cerebral I/R injury in rats and its protective mechanisms. Methods: Twenty minutes of transient global cerebral I/R was induced using the four-vessel occlusion (4-VO) method in rats. PROB was given in the different dose, time and administration routes to verify its neuroprotective effects. Neuronal death in the hippocampal CA1 region was observed using H & E staining 7 days after ischemia. Molecular mechanisms of activation of calpain-cathepsin pathway and inflammatory cells by I/R injury were also investigated. Results: Treatment with PROB (0.1, 1 and 10 mg/kg ) 10 min before ischemia protected against I/R-induced hippocampal CA1 neuronal death significantly, and 1 mg/kg has best protective effect. Post-insult treatment 2h after reperfusion also protected against neuronal death and prolonged use for continuous 7 days could improve its protective effects compared to the single use 6h after reperfusion.Furthermore,oral administration also had protective effect. Cathepsin B expression was inceased significantly in CA-1 region after ischemia and PROB treatment could inhibit its expression. Expression of both calpain-1 and hsp70 at 1d ,2d and 3d after reperfusion were upregulated, whereas the expression of calpain-1 was inhibited and hsp70 was strengthened by pre-treatment with PROB. Prolonged PROB treatment suppressed the activation of microglia and astrocytes, reduced the number of microglia in CA1 region. Conclusions: Our study indicates that PROB protects against transient global cerebral I/R injury administrated before ischemia and even 6h after reperfusion by reducing calpain-1 expression , inhibiting lysosomal rupture and the activation of the glia, which suggests RPOB may be a promising therapeutic drug for clinical treatment of ischemic cerebral injury.

Riluzole is a Promising Pharmacological Inhibitor of Bilirubin‐Induced Excitotoxicity in the Ventral Cochlear Nucleus

Abstract T P84: Neuroprotective Effect of Probenecid in a Rat Model of Transient Global Cerebral Ischemia-Reperfusion

Neuroinflammation in Bilirubin Neurotoxicity.

Bilirubin Potentiates Inhibitory Synaptic Transmission in Lateral Superior Olive Neurons of the Rat.

Bilirubin enhances neuronal excitability by increasing glutamatergic transmission in the rat lateral superior olive.

Bilirubin Facilitates Depolarizing Gaba/Glycinergic Synaptic Transmission in the Ventral Cochlear Nucleus of Rats

Minocycline Cannot Protect Neurons Against Bilirubin-Induced Hyperexcitation in the Ventral Cochlear Nucleus

Bilirubin Inhibits NLRP3 Inflammasome Activation by Maintaining the Stability of Mitochondria Membranes

The Role of Gamma-Aminobutyric Acid/glycinergic Synaptic Transmission in Mediating Bilirubin-Induced Hyperexcitation in Developing Auditory Neurons

NAD+ Attenuates Bilirubin-Induced Hyperexcitation in the Ventral Cochlear Nucleus by Inhibiting Excitatory Neurotransmission and Neuronal Excitability

Ca2+-dependent Recruitment of Voltage-Gated Sodium Channels Underlies Bilirubin-Induced Overexcitation and Neurotoxicity

Selective Vulnerability of GABAergic Inhibitory Interneurons to Bilirubin Neurotoxicity in the Neonatal Brain

The protective effect of riluzole on manganese caused disruption of glutamate–glutamine cycle in rats

NAD+ Attenuates Bilirubin-Induced Augmentation of Voltage-Gated Calcium Currents in Neurons of the Ventral Cochlear Nucleus

Structural basis for the rescue of hyperexcitable cells by the amyotrophic lateral sclerosis drug Riluzole

Protein Kinase A and C Signaling Induces Bilirubin Potentiation of GABA/glycinergic Synaptic Transmission in Rat Ventral Cochlear Nucleus Neurons

Role of glutamate receptor-mediated excitotoxicity in bilirubin-induced brain injury in the Gunn rat model

Taurine Protects Against Bilirubin-Induced Hyperexcitation in Rat Anteroventral Cochlear Nucleus Neurons.

Inhibition of Microglial Activation Ameliorates Inflammation, Reduced Neurogenesis in the hippocampus, and Impaired Brain Function in a Rat Model of Bilirubin Encephalopathy

Biliverdin modulates the Nrf2/A20/eEF1A2 axis to alleviate cerebral ischemia-reperfusion injury by inhibiting pyroptosis

Molecular mechanisms of interaction between the neuroprotective substance riluzole and GABA A -receptors